Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Brief Summary: This phase II trial studies the effectiveness of paclitaxel in treating patients who have ovarian stromal cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.